Bruker Corporation has announced the acquisition of ACQUIFER Imaging GmbH, a pioneer in big-data management solutions for bioimaging and high-content microscopy. This acquisition adds high-performance on-premise processing, secure storage and networking technology that complements Bruker’s advanced fluorescence microscopy imaging products, such as light-sheet and super-resolution microscopy products, which generate high information content...
TESTA Analytical has developed a new Multiple Angle Light Scattering / Differential Refractive Index (MALS / DRI) combination detector package for more demanding Gel Permeation Chromatography (GPC/SEC) applications. Delivering absolute molecular weight data from small to large molecules, MALS has established itself as a tried and trusted GPC/SEC detection technique for polymer, protein, and polysaccharide applications...
As part of its efforts to support emerging biotechnology companies with addressing key challenges of bringing new therapies to market, Thermo Fisher Scientific has announced it has become a founding sponsor of Momentum Labs in Alachua, Fla. Momentum Labs will serve as a collaborative laboratory and office space for growing biotech businesses in the greater Gainesville region...
Eppendorf’s last tubes innovation – the conical tube format 25 mL – comes with new versions: Amber, Protein LoBind® and DNA LoBind®. The innovative material of the amber-colored Conical Tubes 25 mL is highly transparent, while at the same time effectively protecting the sample from low-wavelength light. This way, the pipette tip immersion can be safely monitored during liquid transfer, which helps avoid cross-contamination...
As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics recently introducedHemagglutination Inhibition Assayservices to determine relative concentrations of viruses, bacteria, or antibodies. Hemagglutination inhibition (HI or HAI) is an experimental method invented by the American virologist George Hearst in 1941. This assay utilizes surface proteins of various viruses, such as hemagglutinin (HA) of the influenza virus, to agglutinate red blood cells (RBCs)....
PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, and ThinkCyte K.K, a biotechnology company pioneering novel cell analysis and sorting instruments, has announced a strategic research partnership aimed at advancing modern phenotypic drug screening using artificial intelligence (AI)...
Torrey Pines Scientific, Inc. announces its new EchoTherm™ Model HS65 Programable Digital Stirring Hot Plate with 5 Stirring Positions for use in chemical, pharmaceutical, environmental, biochemical, and other laboratories where reproducible, accurate, hands-off sample preparation and experimentation are a must. With the EchoTherm™ Model HS65, programming is done through the front panel membrane switch and full-functioned custom liquid crystal display...
Agilent Technologies Inc. has announce that the U.S. Food and Drug Administration (FDA) has approved Agilent Resolution ctDx FIRST as a companion diagnostic (CDx) to identify advanced non-small cell lung cancer (NSCLC) patients with KRAS G12C mutations who may benefit from treatment with KRAZATITM (adagrasib). This is the first liquid biopsy NGS assay approved by the FDA as a CDx for the newly approved KRAZATI in advanced NSCLC and was developed in collaboration with Mirati Therapeutics...
Asteria™, the latest breakthrough single-cell RNA-sequencing kit developed by Scipio bioscience, is now commercially available for any researcher worldwide. This innovative hydrogel-based benchtop kit enables the transcriptomic profiling of 10,000 individual cells per sample, instrument-free. By purchasing the kit, researchers also gain access to its intuitive and entirely cloud-based analysis software, Cytonaut™...
Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, announces a selection of new contract wins where Optimer technology is being explored by partners to offer new strategies for therapeutics and potentially offer improved assay sensitivity and selectivity over antibodies. Optimer binders are oligonucleotide-based affinity ligands generated through the in vitro Optimer platform, which can be used as antibody alternatives...
Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, announce the launch of its High Throughput Screening (HTS) capability, as well as the expansion of its state-of-the-art lab and office facilities. Scott Maidment has been appointed as Head of HTS to lead the new service...
AMSBIO reports how the Faculty of Biological Sciences at the University of Leeds (UK) is using their specialty reagents for the production, visualization, and analysis of glycans and to investigate their interactions which are instrumental to the advance of glycobiology. Glycobiology is vital for many biological processes — from fertilization to inflammation — helping unlock information about interactions between carbohydrates and proteins...
Whole-genome sequencing of 35,000 de-identified, diverse genomic DNA samples will begin this month. Illumina Inc., a global leader in DNA sequencing and array-based technologies, and Nashville Biosciences LLC, a wholly owned subsidiary of Vanderbilt University Medical Center (VUMC), have announced an agreement with Amgen, a global biopharmaceutical company, to whole-genome sequence approximately 35,000 DNA samples...
BioPharma Dynamics, a leading life sciences solution provider, proudly expand their extensive portfolio for the Cell & Gene Therapy market to offer a range of chemically defined T-Cell Media, DMSO-Free Cryopreservation Solutions, and Recombinant Growth Factors. Suitable for Cell Therapy applications at any stage, the portfolio of cell media products include Immune Cell Media, Stem Cell Media, and Cell Cryopreservation Solutions....
The UK’s largest distributor of scientific instrumentation, SciMed, has released a new whitepaper that shares advice with the laboratory industry on ways it can become more sustainable without increasing costs or harming experimental efficiency. These include reducing the use of harmful solvents in procedures such as separations and extractions and using new technology that reduces utilities consumption in lab environments...
This strategic acquisition, which follows a long-standing relationship of almost a decade, will allow Astrea Bio to expand its product offering to include a full range of high-performance chromatography columns for biomanufacturing, complementing and strengthening the company’s existing portfolio of bioprocessing resins, reusable columns, and prepacked single-use columns...
Field-based non-dispersive infra-red spectroscopy instrument produces results that were previously only possible using lab-based techniques. A new scientific report by Concawe, which reviewed field-based and lab-based methods of analysing oil-contaminated soils, determined that the InfraCal 2 ATR-SP total petroleum hydrocarbon (TPH) analyser is an effective instrument for measuring oil contamination of soil and water...
Bruker Corporation and Switzerland-based Biognosys AG have announced a strategic partnership, in which Bruker has made a majority-ownership investment in Biognosys. New strategic partnership aims to broaden access to Biognosys’ leading CRO services and Spectronaut® software tools for unbiased proteomics and epiproteomics...
The life science group Sartorius extended a strategic collaboration partnership agreement with RoosterBio Inc. (RoosterBio) to address purification challenges and establish scalable downstream manufacturing processes for exosome-based therapies. Through this collaboration, Sartorius and RoosterBio will provide best-in-class solutions and expertise for a human mesenchymal stem/stromal cell (hMSC) - based exosome production platform that delivers industry-leading yield, purity, and potency...
This new application note describes the analysis of 7 RNA markers (100 – 1000 bases) using the recently introduced bioinert YMC-Accura Triart Bio C4 column at pH 7 and 80 °C. While conventional column hardware leads to peak tailing and loss of recovery when analysing oligonucleotides, the bioinert coated YMC-Accura Triart Bio C4 column shows excellent recoveries and peak shapes for all 7 well resolved markers...
Sally-Anne Whybrow, Healthcare Business Development Manager, Siemens Financial Services, UK explains why CROs are turning to smart finance solutions from specialist financiers. For more than twenty years the trend of outsourcing R&D activities in the pharmaceutical industry has been gaining traction. Driven by the need for continued innovation, outsourcing to a Contract Research Organisation (CRO) has now become a mainstay for pharmaceutical, biotechnology and biomed companies of all sizes...
AMSBIO announce a new range of different isolation products for fast, scalable, and reproducible purification of Extracellular Vesicles (EV), including exosomes, as well as addressing EV heterogeneity and high throughput solutions for biomarker discovery. Traditionally ultracentrifugation has been the favored method for EV isolation or separation. Though it is still widely used, ultracentrifugation not only tends to alter the vesicle shape and functionality but is time-consuming and requires expensive equipment...